Funding · 25 March 2026ELMED Life Sciences$2.7 million (₹25 crore)Probiotic and biological solutions provider
FundingAgriculture & Food Systems
ELMED Life Sciences raises $2.7 million Series A
By Abha Lohia · Editor ·
ELMED Life Sciences: revenue and funding and every story →
Series AHyderabadFounded 2018
- ELMED makes probiotic-based solutions for animal health, agriculture, aquaculture and human health
- It raised $2.7 million in Series A funding from AgriSURE Fund, managed by NABVENTURES
- The company is the first in India to develop probiotics specifically for agriculture
What happened
- ELMED Life Sciences raised $2.7 million (₹25 crore) in Series A funding.
- The round was led by AgriSURE Fund, managed by NABVENTURES, the venture capital arm of NABARD.
- The company will use the funds to expand manufacturing in Hyderabad.
- It will also strengthen R&D in microbiome-based solutions.
- ELMED plans to scale distribution across Tier 2 and Tier 3 Indian markets.
- It aims to build presence in international markets like Europe, Asia and LATAM.
- The company focuses on a ONE HEALTH approach, linking human, animal and environmental health.
Why it matters
- Global and Indian agriculture is shifting to biological and microbiome-based solutions due to antibiotic restrictions and export standards.
- The Indian probiotic segment in animal health, aquaculture and agriculture is growing rapidly.
- Investor interest in microbiome solutions is picking up, with examples like The Good Bug raising ₹100 crore and GreenGrahi raising ₹32 crore.
The business
- ELMED is a science-led company offering probiotic and biological solutions across animal health, aquaculture, agriculture and human health.
- Its products include probiotic-based solutions for poultry, dairy, livestock, shrimp, fish farming and soil/plant health.
- It offers contract manufacturing and R&D services to global healthcare and agri-biotech companies.
- Top clients include Xanum, Hetero Healthcare, Wallace Pharmaceuticals and Donovan.
- Its facility in Hyderabad produces probiotics in oral suspensions, emulsions, drops, capsules, sachets and syrups for humans, aquatic life, animals and plants.
- ELMED is the first company in India to research and develop probiotics specifically for agriculture.
- It follows a B2B approach and serves multiple notable MNCs.
- The company exports to more than 18 countries.
The founders
PR
Pruthivin Reddy Madduri
Founder & Managing Director- He is a VIT alumnus.
- He founded ELMED Life Sciences in 2018.
NK
Nikhil Konkathi
Co-founder- He is a VIT alumnus.
- He co-founded ELMED Life Sciences in 2018.
Who put in money
- AgriSURE Fund lead — AgriSURE Fund is managed by NABVENTURES, the venture capital arm of NABARD.
In numbers
$2.7 million (₹25 crore)Funding amount · 2026
₹17.0 croreRevenue · FY25
₹11.4 croreRevenue · FY24
48.3%Revenue growth · FY25 vs FY24
59Employees · 2026
18+Export countries · 2026
530Web traffic (30 days) · 2026
What happens next
- Expand manufacturing capacity in Hyderabad.
- Strengthen R&D in microbiome-based solutions.
- Scale distribution across Tier 2 and Tier 3 Indian markets.
- Build presence in international markets including Europe, Asia and LATAM.
- Focus on the ONE HEALTH approach.
Words to know
- Series A
- The first significant round of venture capital funding, typically used to scale operations and product development.
- Probiotics
- Live beneficial bacteria that improve health of humans, animals or plants.
- Microbiome
- The community of microorganisms living in a particular environment, such as the gut or soil.
- ONE HEALTH
- An approach that recognizes the interconnection between human health, animal health and the environment.
The numbers around it
Agriculture & Food Systems in March 2026: 9 rounds with a disclosed amount, $97.2 million in all; the biggest was Captain Fresh (Rs 290 crore). Every sector this year →
Other articles talking about it
indian-startup-times ↗Indian Startup Times ↗Pharmabiz ↗Inc42 ↗Entrackr ↗inc42.com ↗Indian Startup News ↗Entrackr ↗Indian Startup News ↗
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
Read next
FundingHenfruit raises $15 million in first outside roundHenfruit sells packaged, graded and lab-tested eggs, and has run on its own money since 2014NewsFarmwiseAI maps 40 million Tamil Nadu land parcelsFarmwiseAI is a Chennai startup, founded around six years ago, that combines artificial intelligence with mapping data to solve farm and land problemsResultsEggoz revenue climbs 39% as losses widenEggoz, a Gurugram brand run by Nupa Technologies, sources eggs from local poultry farmers and supplies retailers within a day
Everything on ELMED Life Sciences → · All startup news on 25 March 2026 →
Is this ELMED Life Sciences? Get your “Featured on StopDown” badge →